Drug-induced lung disease: Keys to diagnosis and management

Clinical Pulmonary Medicine

Volumn 3, Issue 3, 1996, Pages 157-163

  Barry, Scan G ^b   Wesselius, Lewis J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Drug toxicity; Pneumonitis; Pulmonary edema; Pulmonary fibrosis

Indexed keywords

ACETYLSALICYLIC ACID; AMINOSALICYLIC ACID; AMIODARONE; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLEOMYCIN; BUSULFAN; CARBAMAZEPINE; CARMUSTINE; CHLORAMBUCIL; CHLORPROPAMIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOPHOSPHAMIDE; CYTARABINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GALLIUM 67; GOLD; HYDROCHLOROTHIAZIDE; ISONIAZID; MELPHALAN; METHOTREXATE; MITOMYCIN C; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PHENOTHIAZINE; PROCARBAZINE; TERBUTALINE; UTERUS SPASMOLYTIC AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; ALLERGIC PNEUMONITIS; ARTICLE; BRONCHOSPASM; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG INDUCED DISEASE; FIBROSING ALVEOLITIS; HUMAN; INTERSTITIAL PNEUMONIA; INTRAVENOUS DRUG ADMINISTRATION; LUNG BIOPSY; LUNG DIFFUSION CAPACITY; LUNG EDEMA; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG TOXICITY; THORACOSCOPY; THORAX RADIOGRAPHY;

EID: 0029951135     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-199605000-00006     Document Type: Article

References (31)

1. Comis RL. Bleomycin pulmonary toxicity: current status and future directions. Semin Oncol 1992;19:64-70.
2. Bellamy EA, Husband JE, Blaquiere RM, Law MR. Bleomycin-related lung damage: CT evidence. Radiology 1985;156:155-8.
3. Ward-Jones MI, Coursin DB. Perioperative considerations for patients treated with bleomycin. Chest 1991;99:993-9.
4. Dusman RE, Stanton MS, Nules WM, et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation 1990;82:51-9.
5. Greenspan AJ, Kidwell GA, Hurley W, Mannion J. Amiodarone-related postoperative adult respiratory distress syndrome. Circulation 1991;84(III Suppl):407-15.
6. Zitnik RJ, Cooper JAD. Pulmonary disease due to antirheumatic agents. In: Cooper JAD Jr., editor. Clinics in chest medicine. Philadelphia: Saunders, 1990:139-50.
7. Holmberg I, Borman G, Bottizer IE, Erickson B, Spross R, Wessling A. Adverse reactions to nitrofurantoin. Am J Med 1980;69:733-8.
8. Reed CR, Glauscr FL. Drug-induced noncardiogenic pulmonary edema. Chest 1991; 100:1120-4.
9. Anderson BS, Luna MA, Yee C, Hiu KK, Keating MJ, McCrfdie KB. Fatal pulmonary failure complicating high dose cytosine arabinoside therapy in acute leukemia. Cancer 1990;65: 1079-84.
10. Kavaree MS, Ahmod M, Amithalingam KN. Hydrochlorothiazide-induced pulmonary edema. Cleve Clin J Med 1990;57:181-4.
11. Meeker DP, Wiedemann HP. Drug-induced bronchospasm. In: Cooper JAD Jr., editor. Clinics in chest medicine. Philadelphia: Saunders, 1990;163-75.
12. Stoller JK, Elghezawi A, Mehta AC, Vidt DG. Captopril-induced cough. Chest 1988;93:659-61.
13. O'Driscoll BR, Hasleton PS, Taylor PM, Poulter LVV, Gattameneni HR, Woodcock AA. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med 1990;323:378-82.
14. Elsasser S, Dabquen P, Soler M, Perruchoud AP. Methotrexate-induced pneumonitis: appearance four weeks after discontinuation of treatment. Am Rev Respir Dis 1989;140:1089-92.
15. Rosenow EC, Myers JL, Swensen SJ, Pisani RJ. Drug-induced pulmonary disease: an update. Chest 1992;102:239-50.
16. Wolkowicz J, Sturgeon J, Rawic M, Chan CL. Bleomycin-induced pulmonary function abnormalities. Chest 1992;101:97-101.
17. Comis RL, Kuppinger MS, Ginsberg SJ, et al. Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients. Cancer Res 1979;39:5076-80.
18. Gleadhill IC, Wise RA, Schonfeld SA, et al. Serial lung function testing in patients treated with amiodarone: a prospective study. Am J Med 1989;86:4-10.
19. Kennedy JI, Myers JL, Plumb VJ, Fulner JD. Amiodarone pulmonary toxicity. Clinical, radiologic and pathologic correlations. Arch Intern Med 1987;147:50-5.
20. Lewis BM, Izbicki R. Routine pulmonary function tests during bleomycin therapy. JAMA 1980;243:347-51.
21. Kuhlman JE. The role of chest computed tomography in the diagnosis of drug-related reactions. J Thorac Imaging 1991;6:52-61.
22. Moinuddin M. Radionuclide scanning in the detection of drug-induced lung disorders. J Thorac Imaging 1991;6:62-7.
23. Adams PC, Gibson GJ, Morley AR, Wright AJ, Corris PA, Reid DS, et al. Amiodarone pulmonary toxicity: clinical and subclinical features. Q J Med l986;59:449-71.
24. White DA, Kris MG, Stover DE. Bronchoalveolar lavage cell population in bleomycin lung toxicity. Thorax 1987;42:551-2.
25. Ohar JA, Jackson F, Dettenmeier PA, Bedrossian CW, Tricomi SM, Evans RG. Bronchoalveolar lavage cell count and differential are not reliable indications of amiodarone-induced pneumonitis. Chest 1992;102:999-1004.
26. Akoun GM, Mayand CM, Touboul JL, Denis MF, Millscone BJ, Perrot JY. Uses of bronchoalveolar lavage in the evaluation of methotrexate lung disease. Thorax 1987;42:652-5.
27. Jensen L, Goel R, Venner PM. The effect of corticosteroid administration on bleomycin lung toxicity. Cancer 1990;65:1291-7.
28. Van Barneveld PWC, Sceijfer TH, Van Der Mark W, et al. Natural course of bleomycin-induced pneumonitis. Am Rev Respir Dis 1987;135:48-51.
29. Cook NJ, Carroll GJ. Successful reintroduction of methotrexate after pneumonitis in two patients with rheumatoid arthritis. Ann Rheum Dis 1992;51:272-4.
30. Zaher C, Hamer A, Peter T, Mandel W. Low dose steroid therapy for prophylaxis of amiodarone-induced pulmonary infiltrates. N Engl J Med 1983;308:779.
31. Kalaycioglu M, Kavaru M, Tuason L, Bolwell B. Empiric prednisone therapy for pulmonary toxic reaction after high dose chemotherapy containing carmustine (BCNU). Chest 1995; 107:482-7.